Learning Objectives
Upon completion of this activity, participants should be able to:
- Review the results of recent studies on the use of FDA-approved and investigational agents for the treatment of chronic myeloid leukemia
- Discuss new insights into the etiology and prognostic indicators of chronic myeloid leukemia
- Review new data regarding the use of stem cell transplantation in patients with chronic myeloid leukemia
CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.